Xuefeng Zhong

发表论文 7 篇 · 总被引 19 次 · h-index 3

代表论文

Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 study (2025 · EClinicalMedicine · 被引 8)
A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib (2023 · OncoTargets and Therapy · 被引 7)
An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report (2023 · Frontiers in Oncology · 被引 4)
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial (2026 · Nature Communications)
Neoadjuvant toripalimab plus CapeOX in patients with locally advanced EBV-positive gastric or esophagogastric junction adenocarcinoma (GC/EGJC): Results from the phase II NICE trial. (2025 · Journal of Clinical Oncology)
Impact of PD-L1 high expression on the prognosis of patients with locally advanced gastric cancer. (2025 · Journal of Clinical Oncology)